WallStSmart

Agilent Technologies Inc (A)vsQuest Diagnostics Incorporated (DGX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Quest Diagnostics Incorporated generates 56% more annual revenue ($11.28B vs $7.23B). A leads profitability with a 19.6% profit margin vs 9.1%. A appears more attractively valued with a PEG of 1.28. A earns a higher WallStSmart Score of 71/100 (B).

A

Strong Buy

71

out of 100

Grade: B

Growth: 6.7Profit: 8.0Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 1.99

DGX

Buy

58

out of 100

Grade: C

Growth: 6.0Profit: 6.0Value: 5.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASignificantly Overvalued (-73.0%)

Margin of Safety

-73.0%

Fair Value

$74.53

Current Price

$135.44

$60.91 premium

UndervaluedFair: $74.53Overvalued

Intrinsic value data unavailable for DGX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

A2 strengths · Avg: 9.0/10
EPS GrowthGrowth
60.0%10/10

Earnings expanding 60.0% YoY

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

DGX0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

A3 concerns · Avg: 3.7/10
P/E RatioValuation
26.0x4/10

Moderate valuation

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

DGX1 concerns · Avg: 4.0/10
PEG RatioValuation
1.564/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : A

The strongest argument for A centers on EPS Growth, Operating Margin. Profitability is solid with margins at 19.6% and operating margin at 23.7%. PEG of 1.28 suggests the stock is reasonably priced for its growth.

Bull Case : DGX

DGX has a balanced fundamental profile.

Bear Case : A

The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.

Bear Case : DGX

The primary concerns for DGX are PEG Ratio.

Key Dynamics to Monitor

A profiles as a mature stock while DGX is a value play — different risk/reward profiles.

A carries more volatility with a beta of 1.26 — expect wider price swings.

A is growing revenue faster at 10.0% — sustainability is the question.

A generates stronger free cash flow (184M), providing more financial flexibility.

Bottom Line

A scores higher overall (71/100 vs 58/100), backed by strong 19.6% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Agilent Technologies Inc

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.

Quest Diagnostics Incorporated

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Want to dig deeper into these stocks?